Skip to main content

Table 1 Comparison of clinical and laboratory variables of amyloid positive and negative patients with rhumatoid arthritis.

From: Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics

  

Amyloid positive

Amyloid Negative

P* value

- Total patient, no (%)

 

15(6.8)

205(93.2)

-

- Age, yrs, mean ± SD

 

55.2 ± 12(32–75)

51.6 ± 13.2 (22–80)

NS

- Male: Female, no

 

3:12

50: 155

NS

- Age at disease onset yrs. Mean ± SD

 

46.07 ± 7.33 (27–65)

40.18 ± 6.39 (17–70)

NS

- Disease duration, yrs, Mean ± SD

 

9.13 ± 4.67 (5–20)

11.41 ± 6.85 (5–39)

NS

- Constipation no (%)

 

7(46.6)

39(19)

<0.019

- Proteinuria, no. (%)

 

9(60)

17(8.3)

<0.001

- RF. Positive, no. (%)

 

10(66)

130(63.7)

NS

- CRP, *No, (%)

 

13(86)

156(67)

NS

- Receiving DMARD, no, (%)

 

12(80)

155(75.6)

NS

- Past use of gold, no (%)

 

0

17(8.3)

NS

Functional class

Class 3 No (%)

7

49

< 0.5

 

Class 4 No (%)

2

4

 
  1. RF: Rheumatoid Factor; CRP: C-reactive protein; DMARD: Disease Modifying Antirheumatic Drug.
  2. *Normal value <2.3 mg/l.